Alcon's Summit Buy Highlights Increasing Consolidation In Ophthalmic Sector
This article was originally published in The Gray Sheet
Executive Summary
Alcon Labs' recent decision to purchase Summit Autonomous signals a wider trend of consolidation in the ophthalmic device arena, a sector often dismissed by the investment community in recent years as lacking high-growth potential.